| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |